|
HY-D0090-100mg
|
MedChemexpress LLC
|
MQAE [CAS 162558-52-3]
|
|
|
|
|
HY-D0090-200mg
|
MedChemexpress LLC
|
MQAE [CAS 162558-52-3]
|
|
|
|
|
HY-D0090-50mg
|
MedChemexpress LLC
|
MQAE [CAS 162558-52-3]
|
|
|
|
|
HY-D0090-500mg
|
MedChemexpress LLC
|
MQAE [CAS 162558-52-3]
|
|
|
|
|
HY-P74743-10ug
|
MedChemexpress LLC
|
MRAP, Human (HEK293, hFc)
|
|
|
|
|
HY-P74743-5ug
|
MedChemexpress LLC
|
MRAP, Human (HEK293, hFc)
|
|
|
|
|
HY-P74743-50ug
|
MedChemexpress LLC
|
MRAP, Human (HEK293, hFc)
|
|
|
|
|
HY-P76504-10ug
|
MedChemexpress LLC
|
NAPG, Human (His)
|
|
|
|
|
HY-P76504-100ug
|
MedChemexpress LLC
|
NAPG, Human (His)
|
|
|
|
|
HY-P76504-5ug
|
MedChemexpress LLC
|
NAPG, Human (His)
|
|
|
|
|
HY-P76504-50ug
|
MedChemexpress LLC
|
NAPG, Human (His)
|
|
|
|
|
HY-103693-10mg
|
MedChemexpress LLC
|
NAZ2329 [CAS 2809469-05-2]
|
|
Cancer-Kinase/protease
|
|
|
HY-103693-100mg
|
MedChemexpress LLC
|
NAZ2329 [CAS 2809469-05-2]
|
|
Cancer-Kinase/protease
|
|
|
HY-103693-25mg
|
MedChemexpress LLC
|
NAZ2329 [CAS 2809469-05-2]
|
|
Cancer-Kinase/protease
|
|
|
HY-103693-5mg
|
MedChemexpress LLC
|
NAZ2329 [CAS 2809469-05-2]
|
|
Cancer-Kinase/protease
|
|
|
HY-103693-50mg
|
MedChemexpress LLC
|
NAZ2329 [CAS 2809469-05-2]
|
|
Cancer-Kinase/protease
|
|
|
HY-103693-1mL
|
MedChemexpress LLC
|
NAZ2329 [CAS 2809469-05-2] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
|
HY-113970A-10mg
|
MedChemexpress LLC
|
Nebracetam (hydrochloride) [CAS 1177279-49-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-113970A-2mg
|
MedChemexpress LLC
|
Nebracetam (hydrochloride) [CAS 1177279-49-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-113970A-5mg
|
MedChemexpress LLC
|
Nebracetam (hydrochloride) [CAS 1177279-49-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-113970A-1mL
|
MedChemexpress LLC
|
Nebracetam (hydrochloride) [CAS 1177279-49-0] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-104015-10mg
|
MedChemexpress LLC
|
NecroX-5 [CAS 1383718-29-3]
|
|
Cancer-programmed cell death
|
|
|
HY-104015-25mg
|
MedChemexpress LLC
|
NecroX-5 [CAS 1383718-29-3]
|
|
Cancer-programmed cell death
|
|
|
HY-104015-5mg
|
MedChemexpress LLC
|
NecroX-5 [CAS 1383718-29-3]
|
|
Cancer-programmed cell death
|
|
|
HY-104015-50mg
|
MedChemexpress LLC
|
NecroX-5 [CAS 1383718-29-3]
|
|
Cancer-programmed cell death
|
|
